Ahmedabad, Gujarat, India, January 2025 – Sushil Barkur has been appointed as Senior Vice President, Learning & Organizational Development (L&OD) at Cadila Pharmaceuticals Limited. In his new role, Sushil will lead Cadila’s learning and development strategies, drive organizational transformation, and foster a culture of continuous growth and innovation. With over two decades of extensive experience, he is poised to elevate Cadila’s L&OD initiatives to new heights.
In January 2025, Sushil Barkur took on the role of Senior Vice President, Learning & OD at Cadila Pharmaceuticals Limited, focusing on establishing a robust learning culture and advancing organizational development strategies.

Prior to Cadila, Sushil spent over 13 years at Alkem Laboratories Ltd., where he rose to the position of Associate Vice President – L&D, Talent Management, and OD. During his tenure, he drove cultural transformation, spearheaded leadership development programs, and established the Alkem Learning Academy. His efforts contributed to Alkem being recognized as a “Great Place to Work” for three consecutive years.
Before Alkem, Sushil held senior roles at Alembic Pharmaceuticals Limited and Torrent Pharmaceuticals Ltd., where he managed training functions, developed talent management frameworks, and enhanced organizational performance through strategic initiatives. He also contributed to talent development at Nicholas Piramal India Limited, Dr. Reddy’s Laboratories, and Zydus, where he focused on field coaching and specialized training programs.
About Cadila Pharmaceuticals Limited
Founded by Shri I.A. Modi, Cadila Pharmaceuticals Limited is among India’s largest privately-held pharmaceutical companies. Headquartered in Ahmedabad, Gujarat, the company operates in over 100 countries, delivering high-quality pharmaceutical products across 45+ therapeutic areas, including cardiovascular, anti-infectives, and antidiabetics. With a strong focus on research and innovation, Cadila employs more than 300 scientists in its state-of-the-art R&D centers. The company boasts manufacturing facilities in Gujarat, Jammu & Kashmir, and Ethiopia, with several USFDA-approved production units.
Read Also : Entering 2025, TA Leaders’ Success Built on More than Just Hiring, Says The Josh Bersin Company
People Analytics Teams Still Struggle to Deliver Business Impact, Warns The Josh Bersin Company
ESG and Women’s Leadership: Driving Sustainability and Inclusion
Learning and Development Trends for 2025: Shaping the Future of Workplace Learning